Prevention and treatment of Post Novel Virus Conditions with CUHK Immunity Formula (SIM01)

2022-04-29

Post Novel Virus Conditions is defined as the presence of persistent symptoms, such as fatigue, poor memory, difficulty in sleeping or breathing and hair loss, for four weeks or more after clearance of the novel virus. According to a study by CU Medicine, about 80% of patients had Post Novel Virus Conditions six months after recovering from novel virus.

What is Post Novel Virus Conditions?
Persistent symptoms after clearance of novel virus that last > 4 weeks
Persistent symptoms after clearance of novel virus that last > 4 weeks
Cannot be explained by alternative diagnosis
Cannot be explained by alternative diagnosis
Affecting multiple systems
Affecting multiple systems
Not only occur in patients with severe novel virus, but also in people with mild disease
Not only occur in patients with severe novel virus, but also in people with mild disease

A recent pilot study conducted by the research team showed that in patients who received CUHK’s microbiome immunity formula SIM01 for four weeks, over 90% of them did not develop Post Novel Virus Conditions up to a year of follow-up. 

Novel virus patients
(n=36)

Take SIMO1 for 4 weeks

18 months without displaying
Post Novel Virus Conditions

 
A significantly lower percentage of patients in the SIMO1 study had Post Novel Virus Conditions
94% of novel virus patients have no symptoms of "Post Novel Virus Conditions" for 1 year after taking SIMO1

According to the above finding, CU Medicine is currently recruiting recovered novel virus patients who have persistent symptoms into a clinical trial that aims to reduce Post Novel Virus Conditions by modulating their gut microbiota

MORE﹕The CUHK Faculty of Medicine has the world's first certificate of "Post Novel Virus Conditions intestinal microecology". Using intestinal microecology to accurately predict, diagnose and treat "Post Novel Virus Conditions"

https://www.med.cuhk.edu.hk/press-releases/cuhk-researchers-discover-distinct-gut-microbial-signatures-for-prediction-diagnosis-and-treatment-of-post-novel-virus-conditions